As I place my stethoscope on the patient’s chest, often without a word, I reassure myself that at least the patient is ...

Completed enrollment in Phase 2 BESTOW trial assessing tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Presented updat ...

Completed enrollment in Phase 2 BESTOW trial assessing tegoprubart in kidney transplantation four months ahead of schedule; on track to report ...

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) announced its entry into an underwriting agreement with Leerink Partners LLC for the issuance and sale of 17,142,857 shares of its common stock at a price ...

Elon Musk announced that the latest implant procedure was successful and that all three patients who have received the ...

Elon Musk revealed that Neuralink's brain-computer device has been successfully implanted in a third patient, with plans for ...

To achieve the goals set out in its ‘Vision 2030’, argenx has set the following priorities for 2025: Expand the global VYVGART opportunity by reaching more patients broadly across MG, CIDP and ITP ...

When a renowned Israeli TV journalist lost his ability to speak clearly because of ALS, he thought his career might be over.

StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note released on Saturday morning. The firm issued a sell rating on the biopharmaceutical ...

Elon Musk's Neuralink plans to implant upgraded brain-computer interfaces in 20-30 patients this year to help with ...

Channel 12 made the surprising announcement that it would bring Nussbaum back on the air in the coming weeks as a commentator ...